3-(2-(Dimethylamino)Ethyl)-N,N-Dimethylaniline with CAS No: 106274-78-6 is an impurity standard of Rivastigmine.
Rivastigmine is a medication used in the treatment of Alzheimers disease and Parkinsons disease-related dementia. Structurally, it is a carbamate derivative. Rivastigmine belongs to the class of acetylcholinesterase inhibitors, and its primary mechanism of action involves increasing levels of acetylcholine, a neurotransmitter involved in cognitive function, by inhibiting its breakdown. This is particularly beneficial in conditions where there is a deficiency of acetylcholine, as seen in Alzheimers and Parkinsons disease-related dementia. Rivastigmine is available in various formulations, including oral capsules and transdermal patches, allowing for flexibility in administration.
Buy high quality 3-(2-(Dimethylamino)Ethyl)-N,N-Dimethylaniline from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of 3-(2-(Dimethylamino)Ethyl)-N,N-Dimethylaniline